Manufacturing Scalability Determines Cellular Therapy Commercialization
Manufacturing Scalability Determines Cellular Therapy Commercialization The biotechnology sector has witnessed numerous promising cellular therapies fail to achieve meaningful market penetration due to manufacturing constraints. Production scalability—the ability to generate billions of therapeutic cells efficiently and consistently—often determines commercial viability regardless of clinical efficacy. Traditional cellular therapy manufacturing faces multiple bottlenecks. CAR-T production requires complex […]